Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 386

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 386
---
 vest % on the first anniversary of the grant, then monthly to the fourth
anniversary of the date of grant. All awards expire ten years from the date of grant. Options are exercisable only to the extent vested.
The per share purchase price of all restricted stock and the exercise price of all stock options granted under the EIP must be at least
equal to % of the fair value of the Company’s common stock at the date of grant, as determined by the Board of Directors.

|                                     |     | Outstanding 
 Shares      |           |   |     | Weighted         
 Average Exercise 
 Price Per Share  |      |     | Weighted Average 
 Remaining        
 Contractual Life 
 (in years)       |      |
|:------------------------------------|:----|:------------|----------:|:--|:----|:-----------------|-----:|:----|:-----------------|-----:|
| Balance, December 31, 2022          |     |             | 1,138,110 |   |     | $                | 0.29 |     |                  | 8.18 |
| Options exercised                   |     |             |   (24,166 | ) |     | $                | 0.24 |     |                  |      |
| Options cancelled/forfeited/expired |     |             |  (331,445 | ) |     | $                | 0.31 |     |                  |      |
| Balance, December 31, 2023          |     |             |   782,499 |   |     | $                | 0.27 |     |                  | 6.86 |
| Exercisable                         |     |             |   651,663 |   |     | $                | 0.28 |     |                  | 6.60 |

The intrinsic value of options exercised during
the years ended December 31, 2023 and 2022 was $ and $, respectively.

F-63 CERo Therapeutics, Inc. Notes to Financial Statements

|                          |     | 2022 |       |   |
| Risk-free interest rate  |     |      |  2.28 | % |
| Expected life (in years) |     |      |  8.30 |   |
| Expected dividend yield  |     |      |   0.0 | % |
| Estimated volatility     |     |      | 71.31 | % |

|